Skip to main content
. 2020 Oct 22;12(11):1002. doi: 10.3390/pharmaceutics12111002

Figure 1.

Figure 1

Figure 1

Brittle matrix particle morphology of TFF remdesivir compositions; (A) formulations prepared in acetonitrile/water (50/50) co-solvent mixture; (B) formulations prepared in 1,4-dioxane/water (50/50) co-solvent mixture.